Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (OTC Pink - Current Information:GLAXF)

20.95
Real-Time Quote
As of 1:40pm ET
 +0.34 / +1.65%
Today’s Change
18.16
Today|||52-Week Range
22.98
+8.21%
Year-to-Date
Novartis' Acute Heart Failure Drug Fails in Late-Stage Study
Mar 22 / Zacks.com - Paid Partner Content
Merck's (MRK) Keytruda Gets FDA Nod for Lymphoma Indication
Mar 15 / Zacks.com - Paid Partner Content
Jeff Auxier Reduces, Exits Multiple Positions in 4th Quarter
Mar 22 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Intel, Glaxo, Schwab, Travelers and American Airli...
Mar 15 / Zacks.com - Paid Partner Content
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar 21 / Zacks.com - Paid Partner Content
Top Research Reports for Intel, Schwab & Glaxo
Mar 14 / Zacks.com - Paid Partner Content
Still Bullish on GlaxoSmithKline
Mar 21 / TheStreet.com - Paid Partner Content
Novartis Breast Cancer Drug OK'd by FDA as First-line Therapy
Mar 14 / Zacks.com - Paid Partner Content
6 Reasons to Invest in GlaxoSmithKline (GSK) Stock in 2017
Mar 21 / Zacks.com - Paid Partner Content
How a Major Drugmaker Plans to Cure Disease... Without Drugs
Mar 14 / MotleyFool.com - Paid Partner Content
Lilly's Breast Cancer Combo Drug Phase III Results Positive
Mar 21 / Zacks.com - Paid Partner Content
TradeKing vs. Merrill Edge: Best Choice for an IRA Account
Mar 12 / MotleyFool.com - Paid Partner Content
Novartis (NVS) Announces Positive Data on Heart Failure Drug
Mar 20 / Zacks.com - Paid Partner Content
Alexion's sBLA for Soliris Receives FDA Acknowledgement
Mar 10 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar 20 / Zacks.com - Paid Partner Content
Epizyme (EPZM) Reports Narrower Q4 Loss, Pipeline in Focus
Mar 10 / Zacks.com - Paid Partner Content
Why Biotech Stock Gilead (GILD) Could Be a Value Trap
Mar 20 / Zacks.com - Paid Partner Content
Agenus (AGEN) Reports Narrower-than-Expected Loss in Q4
Mar 10 / Zacks.com - Paid Partner Content
Glaxo Files for Label Expansion of Influenza Vaccine in US
Mar 16 / Zacks.com - Paid Partner Content
Why Ionis Pharmaceuticals Rallied 12% in February
Mar 09 / MotleyFool.com - Paid Partner Content